TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
An announcement from Acotec Scientific Holdings Limited ( (HK:6669) ) is now available.
Acotec Scientific Holdings Limited announced that its Endovenous Radiofrequency Ablation System has received 510(k) clearance from the U.S. FDA, marking a significant milestone in its product development. This clearance allows the company to distribute the system, which treats varicose veins, in the U.S. through a partnership with the BSC Group, potentially enhancing its market presence and offering new opportunities for growth.
The most recent analyst rating on (HK:6669) stock is a Hold with a HK$14.00 price target. To see the full list of analyst forecasts on Acotec Scientific Holdings Limited stock, see the HK:6669 Stock Forecast page.
More about Acotec Scientific Holdings Limited
Acotec Scientific Holdings Limited is a company incorporated in the Cayman Islands, focusing on the medical technology industry. The company specializes in developing innovative medical devices, with a particular emphasis on products for treating vascular conditions.
Average Trading Volume: 740,766
Technical Sentiment Signal: Buy
Current Market Cap: HK$4.08B
See more insights into 6669 stock on TipRanks’ Stock Analysis page.